Lilly to present diabetes, obesity drug data at ADA conference
Eli Lilly and Company (NYSE: LLY) will present clinical trial data for its cardiometabolic drugs at the American Diabetes Association's ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
